Company news

Boundless Bio, Inc. news in 2026

Boundless Bio, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

June 22, 2026

Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights

May 8, 2026

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting

April 17, 2026

Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

March 16, 2026

Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

March 8, 2026

Boundless Bio to Participate in the Leerink Global Healthcare Conference

March 4, 2026

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

February 5, 2026

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway

January 20, 2026

Decks in 2026